Ironwood Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.52-$5.78 |
Market Cap | $741.8M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $338.9M |
Revenue Growth (YoY) | 33.3% |
Gross Profit (12 Mos) | $344.1M |
Diluted EPS | $0.18 |
News
See moreYahoo Finance • 4 days ago
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating
Yahoo Finance • 6 days ago
Cheap high flyer healthcare stocks - high momentum and low valuation
Yahoo Finance • 2 months ago
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations
Yahoo Finance • 3 months ago
Ironwood surges after Q3 beat; raised outlook for AbbVie-partnered Linzess
About
CEO | Mr. Thomas A. McCourt |
CFO | Mr. Gregory Martini |
Address | 100 Summer Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 253 |
